Joys of Compounding cover image

Joys of Compounding

Jeff Marrazzo - Compounding for a Cure - [Art of Investing, EP.7]

Nov 27, 2023
Jeff Marrazzo, Co-Founder and former CEO of Spark Therapeutics, discusses the revolutionary breakthrough in gene therapy for inherited retinal disease. He shares the story of Spark Therapeutics, the first company to develop an FDA-approved gene therapy. They also explore the impact of locating a company and research commercialization, merging sectors for making an impact, and the future of life sciences and healthcare.
01:08:34

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

  • Advancements in gene therapy and cell engineering hold the potential to fundamentally cure diseases and revolutionize healthcare.
  • The integration of technology and biology, aided by AI and machine learning, will lead to early disease diagnosis and improved treatment outcomes.

Deep dives

The Power of Gene Therapy in Medicine

The 21st century will be marked by the cure as advancements in gene therapy, gene editing, and cell engineering hold the potential to fundamentally cure diseases. This will revolutionize the way we approach healthcare by addressing the root cause of diseases at the molecular level and restoring normalcy to patients.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner